The Nomination Committee for Humana AB’s Annual General Meeting 2020 has been constituted

The members of the Nomination Committee for Humana AB’s Annual General Meeting in 2020 have now been appointed.

According to the instruction regarding the appointment of the Nomination Committee, applicable until the General Meeting resolves otherwise, Humana AB shall have a Nomination Committee comprising one representative for each of the four principal shareholders in terms of votes and the Chairman of the Board.

Based on the ownership structure as of August 30, 2019 and considering that Argan Capital, which as of this date is Humana's third largest shareholder through the company Air Syndication SCA, has declined to be represented in the Nomination Committee, the following persons have been appointed to members of the Nomination Committee for the 2020 Annual General Meeting:

• Fredrik Strömholm, representative from Impilo Care AB, chairman of the Nomination Committee
• Alexander Kopp, representative from Incentive AS
• Mats Hellström, representative from Nordea Funds Ltd
• Simone Hirschvogl, representative from SEB Investment Management AB
• Sören Mellstig, Humana’s Chairman of the Board

The Nomination Committee shall prepare proposals for the 2020 Annual General Meeting regarding the Chairman of the Annual General Meeting, number of Board members, fees to be paid to each of the Board members, election of Board members and Board Chairman, remuneration to the auditor and election of auditor and, if necessary, proposal for changes in the instruction to the Nomination Committee.

The Annual General Meeting of Humana AB will be held on Thursday, May 7, 2020 in Stockholm. 

Shareholders who wish to present proposals to the Nomination Committee for the 2020 Annual General Meeting can submit them through email to arsstamma@humana.se or by post to Humana AB, AGM, Att: Anna Sönne, Warfvinges väg 39, S-112 51 Stockholm. In order for the Nomination Committee to be able to consider submitted proposals in a constructive manner, these should be submitted by 15 January 2020, at the latest.

For more information, please contact:
Anna Sönne, Head of Investor Relations, +46 70-601 48 53, anna.sonne@humana.se 

Humana is a leading Nordic care company providing services within individual and family care, personal assistance, elderly care and special service housing in accordance with LSS. Humana has some 16,000 employees in Sweden, Norway, Finland and Denmark providing care for 9,000 individuals and working to achieve the vision “Everyone is entitled to a good life”. In 2018, Humana’s operating revenue was SEK 6,725m. Humana is listed on Nasdaq Stockholm since 2016 and the company’s headquarters are located in Stockholm. Read more about Humana on: www.humana.se or corporate.humana.se/en